Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 998,427 | 954,288 | 975,543 | 1,003,578 | 964,095 |
| Cost of Goods | 375,048 | 383,628 | 379,505 | 384,419 | 371,025 |
| Gross Profit | 623,379 | 570,660 | 596,038 | 619,159 | 593,070 |
| Operating Expenses | 306,893 | 309,602 | 292,651 | 355,777 | 294,137 |
| Operating Income | 316,534 | 261,686 | 303,892 | 263,801 | 298,958 |
| Interest Expense | 7,666 | 7,498 | 7,697 | 8,099 | 7,911 |
| Other Income | 1,216 | 2,199 | 2,714 | 3,354 | 4,432 |
| Pre-tax Income | 310,084 | 256,387 | 298,909 | 259,056 | 295,479 |
| Income Tax | 67,407 | 40,238 | 66,068 | 55,758 | 59,900 |
| Net Income Continuous | 242,677 | 216,149 | 232,841 | 203,298 | 235,579 |
| Net Income | $242,677 | $216,149 | $232,841 | $203,298 | $235,579 |
| EPS Basic Total Ops | 2.98 | 2.64 | 2.83 | 2.46 | 2.84 |
| EPS Basic Continuous Ops | 2.98 | 2.64 | 2.83 | 2.46 | 2.84 |
| EPS Diluted Total Ops | 2.96 | 2.62 | 2.80 | 2.44 | 2.81 |
| EPS Diluted Continuous Ops | 2.96 | 2.62 | 2.80 | 2.44 | 2.81 |
| EPS Diluted Before Non-Recurring Items | 2.96 | 2.62 | 2.80 | N/A | N/A |
| EBITDA(a) | $350,597 | $295,392 | $338,025 | $295,994 | $328,862 |